BD Phoenix meropenem-vaborbactam panel

Tuesday, 10 April, 2018 | Supplied by: BD


BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.

The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.

Online: www.bd.com
Phone: 02 8875 7000
Related Products

Mercodia Insulin MBeads Assay

The assay is designed to offer high accuracy by specifically measuring human insulin while...

Waters BD FACSDiscover A7 Cell Analyzer

The BD FACSDiscover A7 Cell Analyzer combines high spectral resolution and sensitivity with...

Lumiprobe CytoTracer fluorescent cell dyes

The dyes rapidly penetrate cells, form intracellular membrane-impermeable products, and deliver...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd